As of Jul 14, 2024, Abcam's P/E ratio was 0, a 0% change from the 0 P/E ratio recorded in the previous year.

The Abcam P/E history

Abcam Aktienanalyse

What does Abcam do?

Abcam PLC is an internationally operating company specializing in the development, manufacturing, and distribution of antibodies and other reagents for life science research. History: Abcam was founded in 1998 by Jonathan Milner, a biologist and cancer researcher who had experienced using antibodies in research. Recognizing a need for high-quality and reliable reagents in this field, he decided to start his own company. In the years following its founding, Abcam grew rapidly and established itself as one of the leading providers of antibodies. In 2005, the company went public on the London Stock Exchange, raising capital for further expansion. Since then, Abcam has made numerous acquisitions and expanded its product portfolio. Business model: Abcam's business model is based on selling antibodies and other reagents to research institutions, universities, and pharmaceutical companies. The company relies on an extensive network of suppliers and partners to offer a wide range of products. Another important aspect of the business model is the online marketing of Abcam's products. The company operates several websites where customers can browse and order the entire product range. To better understand customer needs, Abcam also conducts regular customer surveys and feedback. Divisions: Abcam offers a wide range of products and services, which are grouped into various divisions: Antibodies: The antibodies division is Abcam's core area, encompassing a variety of monoclonal and polyclonal antibodies for various applications. Proteins: Abcam also offers a wide range of proteins for research in areas such as cancer, neurology, and metabolic diseases. Reagents: In addition to antibodies and proteins, Abcam provides a variety of reagents, including kits for biomarker or enzyme activity determination. Services: Abcam also offers a range of services, including custom antibody development, protein expression, and assay development. Products: Abcam offers a wide range of products for use in various areas of life science research. Some of the most well-known products include: Rabbit monoclonal antibodies: These antibodies are highly specific and sensitive, making them valuable tools in cancer research. Chromatin & nucleic acid purification kits: These kits enable efficient purification of DNA, RNA, and chromatin, which is essential for many genomic and epigenomic applications. ELISA kits: Abcam offers a variety of ELISA kits for the determination of biomarkers and other target molecules. Overall, Abcam is a leading provider of antibodies and other reagents for life science research. Through constant innovation and expansion, the company has successfully grown its business in recent years and is now well-positioned worldwide. Abcam ist eines der beliebtesten Unternehmen auf Eulerpool.com.

P/E Details

Deciphering Abcam's P/E Ratio

The Price to Earnings (P/E) Ratio of Abcam is a vital metric that investors and analysts use to determine the company’s market value relative to its earnings. It is calculated by dividing the current stock price by the earnings per share (EPS). A higher P/E ratio could suggest that investors are expecting higher future growth, while a lower ratio may indicate a potentially undervalued company or lower growth expectations.

Year-to-Year Comparison

Assessing Abcam's P/E ratio on a yearly basis provides insights into the valuation trends and investor sentiment. An increasing P/E ratio over the years signifies growing investor confidence and expectations for future earnings growth, while a decreasing ratio may reflect concerns over the company's profitability or growth prospects.

Impact on Investments

The P/E ratio of Abcam is a key consideration for investors aiming to balance risk and reward. A comprehensive analysis of this ratio, in conjunction with other financial indicators, aids investors in making informed decisions regarding buying, holding, or selling the company’s stocks.

Interpreting P/E Ratio Fluctuations

Fluctuations in Abcam’s P/E ratio can be attributed to various factors including changes in earnings, stock price movements, and shifts in investor expectations. Understanding the underlying reasons for these fluctuations is essential for predicting future stock performance and assessing the company's intrinsic value.

Frequently Asked Questions about Abcam stock

What is the price-to-earnings ratio of Abcam?

The price-earnings ratio of Abcam is currently 0.

How has the price-earnings ratio of Abcam changed compared to last year?

The price-to-earnings ratio of Abcam has increased by 0% fallen (meaning "decreased" or "dropped") compared to last year.

What consequences does a high price-earnings ratio have for investors?

A high price-to-earnings ratio indicates that the company's stock is relatively expensive and investors may potentially achieve a lower return.

What does a low price-earnings ratio mean?

A low price-earnings ratio means that the company's stock is relatively cheap and investors may potentially achieve a higher return.

Is the price-earnings ratio of Abcam high compared to other companies?

Yes, the price-to-earnings ratio of Abcam is high compared to other companies.

How does an increase in the price-earnings ratio of Abcam affect the company?

An increase in the price-earnings ratio of Abcam would lead to a higher market capitalization of the company, which in turn would lead to a higher valuation of the company.

How does a reduction in the price-to-earnings ratio of Abcam affect the company?

A decrease in the price-earnings ratio of Abcam would result in a lower market capitalization of the company, which in turn would lead to a lower valuation of the company.

What are some factors that influence the price-earnings ratio of Abcam?

Some factors that influence the price-earnings ratio of Abcam are the company's growth, financial position, industry development, and the overall economic situation.

How much dividend does Abcam pay?

Over the past 12 months, Abcam paid a dividend of 0.04 GBP . This corresponds to a dividend yield of about 0.29 %. For the coming 12 months, Abcam is expected to pay a dividend of 0.49 GBP.

What is the dividend yield of Abcam?

The current dividend yield of Abcam is 0.29 %.

When does Abcam pay dividends?

Abcam pays a quarterly dividend. This is distributed in the months of December, April, December, April.

How secure is the dividend of Abcam?

Abcam paid dividends every year for the past 4 years.

What is the dividend of Abcam?

For the upcoming 12 months, dividends amounting to 0.49 GBP are expected. This corresponds to a dividend yield of 4 %.

In which sector is Abcam located?

Abcam is assigned to the 'Health' sector.

Wann musste ich die Aktien von Abcam kaufen, um die vorherige Dividende zu erhalten?

To receive the latest dividend of Abcam from 4/17/2020 amounting to 0.036 GBP, you needed to have the stock in your portfolio before the ex-date on 3/19/2020.

When did Abcam pay the last dividend?

The last dividend was paid out on 4/17/2020.

What was the dividend of Abcam in the year 2023?

In the year 2023, Abcam distributed 0 GBP as dividends.

In which currency does Abcam pay out the dividend?

The dividends of Abcam are distributed in GBP.

Stock savings plans offer an attractive way for investors to build wealth over the long term. One of the main advantages is the so-called cost-average effect: by regularly investing a fixed amount in stocks or stock funds, you automatically buy more shares when prices are low, and fewer when they are high. This can lead to a more favorable average price per share over time. In addition, stock savings plans allow small investors access to expensive stocks, as they can participate with small amounts. Regular investment also promotes a disciplined investment strategy and helps to avoid emotional decisions, such as impulsive buying or selling. Furthermore, investors benefit from the potential appreciation of the stocks as well as from dividend distributions, which can be reinvested, enhancing the compounding effect and thus the growth of the invested capital.

The Abcam stock can be added to a savings plan with the following providers: Trade Republic

Andere Kennzahlen von Abcam

Our stock analysis for Abcam Revenue stock includes important financial indicators such as revenue, profit, P/E ratio, P/S ratio, EBIT, as well as information on dividends. We also assess aspects such as stocks, market capitalization, debt, equity, and liabilities of Abcam Revenue. If you are looking for more detailed information on these topics, we offer comprehensive analyses on our subpages.